Fig. 6

Correlation of URGPs risk score with MSI, TMB, and drug sensitivity in COAD patients. A The immunity infiltration difference between high- and low-risk scores. B The expression of immune checkpoint genes in the high- and low-risk groups. C Box plot depicting ferroptosis-related gene expression in two groups. D Box plot illustrating the expression of pyroptosis-related genes in two groups. E, F Relationship between the URGPs risk score and the MSI. G Comparison of TMB differences in the high- and low-risk groups. H Pearson correlation analysis of URGPs risk score and TMB. I–M The IC₅₀ of 5 routinely used chemotherapy-related drugs (cisplatin, cytarabine, dasatinib, docetaxel and gemcitabine)